Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations
- PMID: 32567798
- PMCID: PMC7361320
- DOI: 10.1002/alr.22624
Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations
Abstract
Background: Post-viral olfactory dysfunction (PVOD) is one of the most common causes of olfactory loss. Despite its prevalence, optimal treatment strategies remain unclear. This article provides a comprehensive review of PVOD treatment options and provides evidence-based recommendations for their use.
Methods: A systematic review of the Medline, Embase, Cochrane, Web of Science, Scopus, and Google Scholar databases was completed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies with defined olfactory outcomes of patients treated for PVOD following medical, surgical, acupuncture, or olfactory training interventions were included. The Clinical Practice Guideline Development Manual and Conference on Guideline Standardization (COGS) instrument recommendations were followed in accordance with a previously described, rigorous, iterative process to create an evidence-based review with recommendations.
Results: From 552 initial candidate articles, 36 studies with data for 2183 patients with PVOD were ultimately included. The most common method to assess olfactory outcomes was Sniffin' Sticks. Broad treatment categories included: olfactory training, systemic steroids, topical therapies, a variety of heterogeneous non-steroidal oral medications, and acupuncture.
Conclusion: Based on the available evidence, olfactory training is a recommendation for the treatment of PVOD. The use of short-term systemic and/or topical steroids is an option in select patients after careful consideration of potential risks of oral steroids. Though some pharmacological investigations offer promising preliminary results for systemic and topical medications alike, a paucity of high-quality studies limits the ability to make meaningful evidence-based recommendations for the use of these therapies for the treatment of PVOD.
Keywords: budesonide; evidence-based medicine; olfaction disorders; olfactory training; smell; viral infection.
© 2020 ARS-AAOA, LLC.
Figures
Similar articles
-
Therapeutic use of steroids in non-chronic rhinosinusitis olfactory dysfunction: a systematic evidence-based review with recommendations.Int Forum Allergy Rhinol. 2019 Feb;9(2):165-176. doi: 10.1002/alr.22240. Epub 2018 Nov 24. Int Forum Allergy Rhinol. 2019. PMID: 30472771
-
Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis.Otolaryngol Head Neck Surg. 2021 Feb;164(2):244-254. doi: 10.1177/0194599820943550. Epub 2020 Jul 14. Otolaryngol Head Neck Surg. 2021. PMID: 32660334
-
Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review.Front Neurosci. 2021 Aug 12;15:708510. doi: 10.3389/fnins.2021.708510. eCollection 2021. Front Neurosci. 2021. PMID: 34456675 Free PMC article.
-
Treatment strategies for postviral olfactory dysfunction: A systematic review.Allergy Asthma Proc. 2022 Mar 1;43(2):96-105. doi: 10.2500/aap.2022.43.210107. Allergy Asthma Proc. 2022. PMID: 35317886 Free PMC article.
-
The effect of traditional Chinese medicine treatment for post-viral olfactory dysfunction: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2021 Apr 23;100(16):e25536. doi: 10.1097/MD.0000000000025536. Medicine (Baltimore). 2021. PMID: 33879697 Free PMC article.
Cited by
-
The Effect of Corticosteroids on Post-Covid-19 Smell Loss: A Meta-Analysis.Iran J Otorhinolaryngol. 2023 Sep;35(130):235-246. doi: 10.22038/IJORL.2023.72451.3456. Iran J Otorhinolaryngol. 2023. PMID: 38090618 Free PMC article.
-
Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19.Curr Res Pharmacol Drug Discov. 2021;2:100035. doi: 10.1016/j.crphar.2021.100035. Epub 2021 Jun 5. Curr Res Pharmacol Drug Discov. 2021. PMID: 34870148 Free PMC article. Review.
-
Management of post-COVID-19 olfactory dysfunction.Curr Treat Options Allergy. 2022;9(1):1-18. doi: 10.1007/s40521-021-00297-9. Epub 2022 Jan 4. Curr Treat Options Allergy. 2022. PMID: 35004126 Free PMC article. Review.
-
Evaluation of effects of chronic nasal steroid use on rhinological symptoms of COVID-19 with SNOT-22 questionnaire.Pharmacol Rep. 2021 Jun;73(3):781-785. doi: 10.1007/s43440-021-00235-1. Epub 2021 Feb 24. Pharmacol Rep. 2021. PMID: 33625686 Free PMC article.
-
Intensive Olfactory Training in Post-COVID-19 Patients: A Multicenter Randomized Clinical Trial.Am J Rhinol Allergy. 2022 Nov;36(6):780-787. doi: 10.1177/19458924221113124. Epub 2022 Jul 21. Am J Rhinol Allergy. 2022. PMID: 35866202 Free PMC article. Clinical Trial.
References
-
- Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology. 2017;54:1‐30. - PubMed
-
- Deems DA, Doty RL, Settle G, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Neck Surg. 1991;117(5):519‐528. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical